Get started
Author

Michael Tolentino

Observed names: M Tolentino, M. Tolentino
OpenAlex ID: A5113813424
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
2011 · Peter A. Campochiaro, David M. Brown, et al. · Ophthalmology · 407
Progression of Geographic Atrophy in Age-related Macular Degeneration
2018 · Tiarnan D. Keenan, Elvira Agrón, et al. · Ophthalmology · 225
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression
2022 · Emily Y. Chew, Traci E. Clemons, et al. · JAMA Ophthalmology · 189
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial
2016 · Pravin U. Dugel, Michael Tolentino, et al. · Ophthalmology · 103
Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2
2014 · Peter A. Campochiaro, Raafay Sophie, et al. · Ophthalmology · 96
PDF
The Effect of a Head‐mounted Low Vision Device on Visual Function
2018 · Walter Wittich, Marie‐Céline Lorenzini, et al. · Optometry and Vision Science · 63
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration
2018 · Jeannette J. Yu, Elvira Agrón, et al. · Ophthalmology · 60
Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study
2010 · T. R. Friberg, M. Tolentino, et al. · British Journal of Ophthalmology · 50
PDF
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
2017 · Peter K. Kaiser, Michael Singer, et al. · Ophthalmology Retina · 42
Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration
2013 · Ronald Danis, Megan M McLaughlin, et al. · British Journal of Ophthalmology · 32
Initial Exploration of Oral Pazopanib in Healthy Participants and Patients With Age-Related Macular Degeneration
2013 · Megan M. McLaughlin, Marcella G. Paglione, et al. · JAMA Ophthalmology · 31
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
2024 · Yasir Jamal Sepah, Diana V. Do, et al. · Eye · 19
PDF
Association of Dietary Nitrate and a Mediterranean Diet With Age-Related Macular Degeneration Among US Adults
2022 · Geoffrey K. Broadhead, Elvira Agrón, et al. · JAMA Ophthalmology · 18
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial
2023 · Steven M. Kymes, Neal L. Oden, et al. · JAMA Ophthalmology · 10
Long-term Clinical Outcomes with Ocriplasmin: The OASIS Study - Baseline Demographics and Ocular Characteristics
2014 · Michael Tolentino · Investigative Ophthalmology & Visual Science · 2
Multifocal Electroretinography Outcomes Following AVD-104 Treatment for Geographic Atrophy
2026 · Nathan N. Macha, Minzhong Yu, et al. · Journal of VitreoRetinal Diseases · 1
Complications of Anti-Vascular Endothelial Growth Factor Drugs
2012 · Michael Tolentino · Current Drug Therapy · 1
BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints]
2025 · The BRIDGE Study Group, Sobha Sivaprasad, et al. · Eye
PDF
The Importance of Assessing Dark Adaptation in Patients with Age Related Macular Degeneration
2018 · Michael Tolentino, Manuel Paez-Escamilla, et al.
Works count: 19
Citation count: 1,349
H-index: 13
I10-index: 14
Year
Topic
Type